Nexalin Technology
15 hedge funds and large institutions have $287K invested in Nexalin Technology in 2024 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 5 closing their positions.
60% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 5
15% more funds holding
Funds holding: 13 → 15 (+2)
0.41% more ownership
Funds ownership: 3.64% → 4.05% (+0.41%)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
39% less capital invested
Capital invested by funds: $467K → $287K (-$180K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$106K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$60K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$43.7K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$35.7K |
| 5 |
VF
Virtu Financial
New York
|
+$24.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$101K |
| 2 |
AWS
Atria Wealth Solutions
New York
|
-$21.8K |
| 3 |
Squarepoint
New York
|
-$21.3K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$5.07K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.4K |
NXL Hedge Fund Activity: Q3 2024 in Review
15 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Nexalin Technology (NXL) for Q3 2024, worth a combined $287K — down 39% from $467K a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new NXL positions and 5 closed out — a net gain of 3 holders — while 2 added to existing stakes and 3 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $106K. The largest seller was Morgan Stanley, exiting entirely with an estimated $101K sold.
- 15 institutional investors held Nexalin Technology (NXL) as of Q3 2024, up from 13 in Q2 2024.
- Funds reported $287K of Nexalin Technology stock for Q3 2024, down 39% quarter-over-quarter.
- 8 funds opened new Nexalin Technology positions in Q3 2024 and 5 closed out, a net change of +3 holders.
- The largest Nexalin Technology buyer in Q3 2024 was Renaissance Technologies, an estimated $106K added.
- The largest Nexalin Technology seller in Q3 2024 was Morgan Stanley, an estimated $101K sold.
Based on aggregated 13F filings for Q3 2024.